NZ195596A - 1-oxo-1h-thiazolo(3,2-a)pyramidine-2-carboxamide derivatives and pharmaceutical compositions - Google Patents

1-oxo-1h-thiazolo(3,2-a)pyramidine-2-carboxamide derivatives and pharmaceutical compositions

Info

Publication number
NZ195596A
NZ195596A NZ195596A NZ19559680A NZ195596A NZ 195596 A NZ195596 A NZ 195596A NZ 195596 A NZ195596 A NZ 195596A NZ 19559680 A NZ19559680 A NZ 19559680A NZ 195596 A NZ195596 A NZ 195596A
Authority
NZ
New Zealand
Prior art keywords
oxo
pyrimidine
hydrogen
compound
ethyl
Prior art date
Application number
NZ195596A
Other languages
English (en)
Inventor
S B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ195596A publication Critical patent/NZ195596A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NZ195596A 1979-11-23 1980-11-20 1-oxo-1h-thiazolo(3,2-a)pyramidine-2-carboxamide derivatives and pharmaceutical compositions NZ195596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (1)

Publication Number Publication Date
NZ195596A true NZ195596A (en) 1984-05-31

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ195596A NZ195596A (en) 1979-11-23 1980-11-20 1-oxo-1h-thiazolo(3,2-a)pyramidine-2-carboxamide derivatives and pharmaceutical compositions

Country Status (35)

Country Link
JP (1) JPS5687586A (nl)
KR (1) KR830004322A (nl)
AR (2) AR228859A1 (nl)
AT (1) AT380883B (nl)
AU (1) AU520995B2 (nl)
BE (1) BE886319A (nl)
CA (1) CA1143731A (nl)
CH (1) CH649299A5 (nl)
CS (1) CS241476B2 (nl)
DD (1) DD154608A5 (nl)
DE (2) DE3043979C2 (nl)
DK (1) DK151811C (nl)
EG (1) EG14929A (nl)
ES (1) ES8203363A1 (nl)
FI (1) FI67706C (nl)
FR (1) FR2470132A1 (nl)
GB (1) GB2063862B (nl)
GR (1) GR72132B (nl)
GT (1) GT198066458A (nl)
HU (1) HU179091B (nl)
IE (1) IE50404B1 (nl)
IL (1) IL61535A (nl)
IN (1) IN154926B (nl)
IT (1) IT1209373B (nl)
LU (1) LU82950A1 (nl)
NL (1) NL182565C (nl)
NO (1) NO803521L (nl)
NZ (1) NZ195596A (nl)
PH (1) PH16666A (nl)
PL (1) PL132354B1 (nl)
PT (1) PT72090B (nl)
SE (1) SE448732B (nl)
SU (1) SU1042620A3 (nl)
YU (1) YU41953B (nl)
ZA (1) ZA807293B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
ATA570780A (de) 1985-12-15
CS782080A2 (en) 1985-06-13
NL8006362A (nl) 1981-06-16
HU179091B (en) 1982-08-28
ZA807293B (en) 1981-12-30
IN154926B (nl) 1984-12-22
NL182565B (nl) 1987-11-02
FR2470132A1 (fr) 1981-05-29
IL61535A0 (en) 1980-12-31
IE50404B1 (en) 1986-04-16
CS241476B2 (en) 1986-03-13
DK151811B (da) 1988-01-04
GB2063862B (en) 1983-06-22
DE3043979C2 (de) 1986-08-21
AT380883B (de) 1986-07-25
NO803521L (no) 1981-05-25
IE802418L (en) 1981-05-23
ES497066A0 (es) 1982-04-01
KR830004322A (ko) 1983-07-09
PH16666A (en) 1983-12-13
DK413180A (da) 1981-05-24
JPS617432B2 (nl) 1986-03-06
YU295080A (en) 1983-06-30
SE448732B (sv) 1987-03-16
AU6459580A (en) 1981-05-28
CH649299A5 (fr) 1985-05-15
PT72090B (en) 1981-09-29
AR228859A1 (es) 1983-04-29
PT72090A (en) 1980-12-01
FR2470132B1 (nl) 1983-07-29
IT1209373B (it) 1989-07-16
FI67706C (fi) 1985-05-10
FI803628L (fi) 1981-05-24
PL132354B1 (en) 1985-02-28
LU82950A1 (fr) 1981-06-04
BE886319A (fr) 1981-05-25
GB2063862A (en) 1981-06-10
DE3050491C2 (de) 1985-10-10
SU1042620A3 (ru) 1983-09-15
SE8008189L (sv) 1981-05-24
ES8203363A1 (es) 1982-04-01
EG14929A (en) 1989-01-30
PL228008A1 (nl) 1981-12-11
IL61535A (en) 1984-06-29
DK151811C (da) 1988-06-06
GR72132B (nl) 1983-09-19
IT8026176A0 (it) 1980-11-21
NL182565C (nl) 1988-04-05
AR231296A1 (es) 1984-10-31
AU520995B2 (en) 1982-03-11
GT198066458A (es) 1982-05-15
CA1143731A (en) 1983-03-29
JPS5687586A (en) 1981-07-16
DE3043979A1 (de) 1981-09-03
DD154608A5 (de) 1982-04-07
YU41953B (en) 1988-02-29
FI67706B (fi) 1985-01-31

Similar Documents

Publication Publication Date Title
US4233299A (en) 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof
US4174397A (en) Thiazolidine derivatives
US4075343A (en) Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
CA1109870A (en) Azolopyrimidinones
US4041163A (en) N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
US4734413A (en) Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators
NZ195596A (en) 1-oxo-1h-thiazolo(3,2-a)pyramidine-2-carboxamide derivatives and pharmaceutical compositions
US4423048A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4535081A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
NZ188770A (en) Thiazolinylguanidine derivatives and pharmaceutical compositions
US4414388A (en) 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
US4321372A (en) Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4705787A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0121341B1 (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
JPH01319487A (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
NZ203034A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives
US4908364A (en) Substituted 3-phenyl-7H-thiazol[3,2-b][1,2,4]-triazin-7-ones
CA1095524A (en) Antiinflammatory imidazothiazoles
US4349674A (en) Quinoalinyl esters of carbamimidothioic acids
US4269774A (en) Thiazolo[5,4-d][2]benzazepines
IE43028B1 (en) Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them
US4085213A (en) Tetrazolo[A]quinazol-5-ones antiallergy and antiulcer agents
FI71158B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-xo-1h-tiazolo/3,2-a/pyrimidin-2-karboxylsyror
US4491587A (en) Tetrazole derivatives
US3755312A (en) 6-substituted-1, 2,4-pyrimido{8 4,5-e{9 thiadiazine-1,1-dioxides